221 related articles for article (PubMed ID: 29604567)
1. Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.
Fang S; Hou Y; Ling L; Wang D; Ismail M; Du Y; Zhang Y; Yao C; Li X
Colloids Surf B Biointerfaces; 2018 Jun; 166():235-244. PubMed ID: 29604567
[TBL] [Abstract][Full Text] [Related]
2. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
[TBL] [Abstract][Full Text] [Related]
3. Novel dual VES phospholipid self-assembled liposomes with an extremely high drug loading efficiency.
Hou Y; Yao C; Ling L; Du Y; He R; Ismail M; Zhang Y; Fu Z; Li X
Colloids Surf B Biointerfaces; 2017 Aug; 156():29-37. PubMed ID: 28499202
[TBL] [Abstract][Full Text] [Related]
4. Self-assembled liposomes of dual paclitaxel-phospholipid prodrug for anticancer therapy.
Ling L; Du Y; Ismail M; He R; Hou Y; Fu Z; Zhang Y; Yao C; Li X
Int J Pharm; 2017 Jun; 526(1-2):11-22. PubMed ID: 28412448
[TBL] [Abstract][Full Text] [Related]
5. Assembled liposomes of dual podophyllotoxin phospholipid: preparation, characterization and in vivo anticancer activity.
Ling L; Yao C; Du Y; Ismail M; He R; Hou Y; Zhang Y; Li X
Nanomedicine (Lond); 2017 Mar; 12(6):657-672. PubMed ID: 28244817
[TBL] [Abstract][Full Text] [Related]
6. Liposomes of dimeric artesunate phospholipid: A combination of dimerization and self-assembly to combat malaria.
Ismail M; Ling L; Du Y; Yao C; Li X
Biomaterials; 2018 May; 163():76-87. PubMed ID: 29454237
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive dimeric camptothecin phosphatidylcholines-based liposomes for improved anticancer efficacy.
He W; Du Y; Zhou W; Yao C; Li X
Nanomedicine (Lond); 2019 Dec; 14(23):3057-3074. PubMed ID: 31696756
[No Abstract] [Full Text] [Related]
8. Liposomes assembled from dimeric retinoic acid phospholipid with improved pharmacokinetic properties.
Lu L; Du Y; Ismail M; Ling L; Yao C; Fu Z; Li X
Eur J Pharm Sci; 2018 Jan; 112():186-194. PubMed ID: 29162478
[TBL] [Abstract][Full Text] [Related]
9. Dimeric artesunate phospholipid-conjugated liposomes as promising anti-inflammatory therapy for rheumatoid arthritis.
Zhang Y; He W; Du Y; Du Y; Zhao C; Zhang Y; Zhang H; Yin L; Li X
Int J Pharm; 2020 Apr; 579():119178. PubMed ID: 32105722
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy.
Ma W; Su H; Cheetham AG; Zhang W; Wang Y; Kan Q; Cui H
J Control Release; 2017 Oct; 263():102-111. PubMed ID: 28082170
[TBL] [Abstract][Full Text] [Related]
11. Core-crosslinked nanomicelles based on crosslinkable prodrug and surfactants for reduction responsive delivery of camptothecin and improved anticancer efficacy.
He W; Du Y; Zhou W; Wang T; Li M; Li X
Eur J Pharm Sci; 2020 Jul; 150():105340. PubMed ID: 32371069
[TBL] [Abstract][Full Text] [Related]
12. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
13. Dual sensitive and temporally controlled camptothecin prodrug liposomes codelivery of siRNA for high efficiency tumor therapy.
Li Y; Liu R; Yang J; Ma G; Zhang Z; Zhang X
Biomaterials; 2014 Dec; 35(36):9731-45. PubMed ID: 25189519
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Lipid Composition on the Liposomal Delivery of Camptothecin Developed by Active Click Loading.
Xie L; Zhang Q; Zhu Q; Wang Y; Niu S; Zhang X; Huang Y; Li J; Liu X; Xue Z; Zhao X; Zheng Y
Mol Pharm; 2024 May; 21(5):2327-2339. PubMed ID: 38576375
[TBL] [Abstract][Full Text] [Related]
15. Evaluation the synergistic antitumor effect of methotrexate-camptothecin codelivery prodrug from self-assembly process to acid-catalyzed both drugs release: A comprehensive theoretical study.
Pakdel M; Raissi H; Hosseini ST
J Comput Chem; 2020 Jun; 41(16):1486-1496. PubMed ID: 32190916
[TBL] [Abstract][Full Text] [Related]
16. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
[TBL] [Abstract][Full Text] [Related]
17. Artificial lipids stabilized camptothecin incorporated in liposomes.
Maitani Y; Katayama S; Kawano K; Hayama A; Toma K
Biol Pharm Bull; 2008 May; 31(5):990-3. PubMed ID: 18451532
[TBL] [Abstract][Full Text] [Related]
18. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
Stano P; Bufali S; Pisano C; Bucci F; Barbarino M; Santaniello M; Carminati P; Luisi PL
J Liposome Res; 2004; 14(1-2):87-109. PubMed ID: 15461935
[TBL] [Abstract][Full Text] [Related]
19. Liposomal formulations of poorly soluble camptothecin: drug retention and biodistribution.
Flaten GE; Chang TT; Phillips WT; Brandl M; Bao A; Goins B
J Liposome Res; 2013 Mar; 23(1):70-81. PubMed ID: 23210622
[TBL] [Abstract][Full Text] [Related]
20. The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.
Kim SH; Kaplan JA; Sun Y; Shieh A; Sun HL; Croce CM; Grinstaff MW; Parquette JR
Chemistry; 2015 Jan; 21(1):101-5. PubMed ID: 25384556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
